OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2020-12-31-accounts

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group) (Limited by Guarantee)

Trustees Report and Financial Statements

Registered Charity Number: 1085527 Company Number: 04133242

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Contents Page
Trustees’ Report 1 - 11
Auditors’ report 12 - 13
Statement of Financial Activities 14
Balance sheet 15
Statement of cash-flows 16
Notes to the Accounts 17 – 27

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ Report

Legal and Administrative Information Year ended 31 December 2020

_______________ Reference and administration details of the charity, its Trustees and advisors

Company Number: 04133242 Charity Number: 1085527

Patrons Hon. President Mark Foster David Reading OBE Giorgio Locatelli Jo Frost

Trustees

Trustees who are directors for the purpose of company law and trustees for the purpose of charity law, who served during the year, are as follows:

Mrs Sarah Lassman Chair Ms Alison Skinner Hon. Treasurer – Retired April 2021 Mrs Sue Clarke Retired December 2020 Mr Boaz Gaventa Dr Alison Walker-Fraser Dr Joanne Walsh Mr Chris Meads Appointed December 2020 Mrs Louise Wilkinson Appointed December 2020 Mrs Taj Randhawa Appointed December 2020 Mr Peter Littleton Appointed December 2020

Chief Executive of Anaphylaxis Campaign

Mrs J. L. Regent

Registered office

1 Alexandra Road Farnborough Hampshire GU14 6BU

Operational Office 1 Alexandra Road Farnborough Hampshire GU14 6BU

Website: www.anaphylaxis.org.uk

Bankers

HSBC Bank plc 54 High Street Epsom Surrey KT19 8DS

Investment Advisors

Hargreaves Lansdown One College Square South Anchor Road Bristol BS1 5HL

Solicitors

Independent Auditor

Stone King LLP Chamberlains Boundary Street Elm House 91 Charterhouse Street Shackleford Road London EC1M 6HR Elstead GU8 6LB

1

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report Year ended 31 December 2020

_____________ The Trustees, who are also the Directors of the Charity for the purposes of the Companies Act, are pleased to present their report, together with the financial statements for the Year ended 31 December 2020.

2020 – Our Impact

2

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________

Company Information

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group) (the ‘Campaign’) was incorporated under the Companies Act on 29 December 2000 and is a company limited by guarantee. The Campaign was registered as a charity on 13 March 2001 and its governing document is a Memorandum of Association dated 29 December 2000. The Campaign is also recognised by HM Revenue & Customs as a charity for tax purposes.

The objectives of the Campaign are:

1. To advance the education and general understanding of the public concerning life-threatening allergies and associated disorders

2. To protect the health of people who are at risk of severe allergic reactions by providing help and information to them, their families and friends.

3. To promote research into the cause and care of severe allergic conditions and to publish the results of such research.

How the Campaign’s objectives benefit the public.

Severe allergic conditions, whether in a young child, teenager or adult, can have a devastating effect on everyday life, not just for those at risk, but also for their families. Our aim is to:

The Trustees have referred to the guidance contained in the Charity Commission’s guidance on public benefit when reviewing our 3-year Strategic Plan, which set out our activities for the period 2019 – 2021 to meet our objectives.

Objective 1. To advance the education and general understanding of the public concerning life-threatening allergies and associated disorders.

What we said we would do: be the principal trusted source of information about anaphylaxis in the UK

3

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________ What we did in 2020:

a. through building and maintaining our reputation as a provider of quality information.

b. through our training programmes

4

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________

c. engagement achieved through our website, courses and social media platforms

d. for the food industry

e. for clinicians

5

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________

Objective 2. To protect the health of people at risk of severe allergic reactions by providing help and information to them, their families and friends.

What we said we would do: Campaign on behalf of people at risk of severe allergic reactions What we did in 2020:

As part of our Universities and Adults project:

As part of our Making Schools Safer Project:

As part of our Food Services Project:

We used our database of Local Authorities and Trading Standards to share best practice and learnings from coroner inquests in two mailings opened by 136 local authorities.

6

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________

As part of our Primary Care Project:

Objective 3. To promote research into the cause and care of severe allergic conditions and to publish the results of such research.

What we said we would do: support and fund research that improves services and quality of life for patients: What we did in 2020:

Facilitated many research projects – the Campaign assisted the following organisations with research projects into severe allergies during 2020:

Structure, Governance and Management

The Campaign’s Memorandum of Association sets out the objects and powers of the charitable company and is governed under its Articles of Association. Under those Articles, the Trustees are elected at the Annual General Meeting to serve for a period of approximately three years.

Trustees are recruited to ensure a balanced board with a mix of skills. All new Trustees are given an induction which includes learning about the background, ethos and day to day activities of the Campaign as well as outlining their responsibilities. The maximum number of Trustees allowed by the Campaign’s governing document is eleven and at 31 December 2020 there were nine. Trustees may be co-opted by the board as considered necessary and those co-opted may serve until the Annual General Meeting following their co-option, at which time they must stand for election if they wish to remain on the Board.

The Governance structure is made up of a Board of Trustees. The Chief Executive is not a Trustee but a permanent non-voting member of the Board, with the right to attend all Board meetings unless a conflict of interest exists. The Business Manager for the Campaign is also its Company Secretary. Other members of staff from the Campaign attend as required.

7

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________ The Board usually meets quarterly and holds an annual Strategy Day in addition, which all Trustees and the Chief Executive are expected to attend. Trustees may also attend any of the Campaign’s conferences and events relevant to their particular roles during the year. From the beginning of April 2020 to December 2020 Board meetings were held monthly via Zoom.

The Campaign operates in a consistent way by following the policies set out and agreed by the Board, supported and implemented by the Chief Executive, Mrs. Lynne Regent and her staff. Day to day responsibility rests with the Chief Executive, who is responsible for all staff.

Strategy 2019-2021

The key objectives for 2019-2021 were set out in the Business Plan 2019 agreed by the Board in March 2019. The key priorities for the Campaign were agreed as follows;

The Business plan has been monitored by the Board at each of their meetings. The performance objectives of each member of staff directly relate to the Business Plan and the overall strategic direction.

From April 2020 all staff worked virtually from home with full electronic, but secure access to central files. With technical support the Helpline and Information Team provided a full service as demand for our advice increased markedly in 2021. Our CEO held weekly virtual meetings with all staff participating via a sound and visual link as well as one to one meetings. A member of staff visited our office on a weekly basis to process incoming post. During this period all staff received diversity training.

Investment performance achieved against investment objectives

The investment objectives of the Campaign are to maximise the value of reserves, while avoiding undue risk. The Campaign’s policy on investment includes a requirement to limit investments to 60% of liquid assets and only to invest in Funds regulated by the Financial Conduct Authority. The Campaign’s investments in an Income and Growth portfolio with Hargreaves Lansdown showed a loss of £6,941 on the value report at the end of December 2019 (£163,091). The value at the end of December 2020 was £156,150.

8

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_____________

Financial review Reserves policy

To achieve a sound balance between prudence and ensuring funds are expended in achieving the objectives of the Campaign, the Trustees have established a policy whereby the unrestricted reserves held by the Campaign should equate to at least six months operating cost. At the year end this equated to £252,384. Free reserves (excluding 6 months operating costs) at 31 December 2020 stood at £300,954.

Restricted reserves

Details of restricted funds are shown in note 16 of the financial statements.

Risk review

The Trustees have conducted a review of the major risks to which the Campaign is exposed and systems have been established to manage those risks. A risk management register is maintained and risks highlighted are reviewed regularly to ensure they do not pose a threat to the Campaign going forward. Key risks for the Campaign include potential for loss of expertise and/or revenue from donations and fundraising activities. All Trustees received regular governance training.

Financial overview

The Campaign ended the year in a sound financial position with £7,496 already in hand to fund projects in 2021 and sufficient free reserves to meet its reserves policy. Net outgoing resources for the year amounted to £495,062. Unrestricted funds were £553,338 and restricted funds £7,496. COVID has had a significant impact on the operations of the Anaphylaxis Campaign, including the need to change employment contracts to deal with furlough. Detailed consideration is being given to further changes to the organisation that might be implemented. As a consequence, legal fees have been considerably higher in the year under review.

Financial policies

All payments up to £10,000 made by the Campaign have to be signed by two authorised signatories and by a Trustee in addition for payments over that amount. The day-to-day management of the financial affairs of the Campaign is delegated to the Business Manager who submits Management Accounts and a written report monthly to the CEO and Board of Trustees. A financial report supported by Management Accounts is delivered at each meeting of Trustees.

Principal funding sources

The principal funding sources for the Campaign are donations from a variety of individuals and Gift Aid and membership subscriptions. The Campaign seeks funds from companies, charitable trusts and other sources to fund running costs and specific projects.

We are particularly grateful for grants from the Barbara Ward Children’s Foundation and the Garfield Weston Foundation.

Uses of funds

The funds received by the Campaign during the year have helped to finance our Helpline and Information services, Support Group development, Adult Allergy campaigns, outreach to young people with severe allergies, research programmes, and our training for health professionals.

9

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

Plans for the future

The Board have agreed a Strategic Framework for 2019-2021. The general impact the Anaphylaxis Campaign aims to achieve by the end of 2021 is:

Our main priority areas and the impact we aim to achieve within each area are set out in the Business Plan approved by the Board in March 2019.These priorities are reflected in the Business Plan which were approved by the Board in March 2019. The main areas for future work will be:

The Board will agree a new strategic direction in 2021 for 2021 to 2023. Also a consultation was held in December 2020 regarding proposed constitutional changes for the charity. It is envisaged that these changes will be implemented in 2021.

10

Anaphylaxis Campaign (incorporating the Latex Allergy Support Group)

Trustees’ report (continued) Year ended 31 December 2020

_______________

Statement of Trustees’ responsibilities

The trustees (who are also directors of the Campaign for the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the trustees are required to:

The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the trustees are aware:

The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

Auditor

Chamberlains were appointed auditors at the Annual General Meeting of the Campaign held on 11[th] December 2019. The AGM for 2020 was deferred.

This report has been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.

This report was approved by the Trustees on 28 June 2021 and signed on their behalf.

Mrs. Sarah Lassman

Chair

11

Independent Auditor’s Report to the Members of The Anaphylaxis Campaign (Incorporating the Latex Allergy Support Group)

Opinion

We have audited the financial statements of The Anaphylaxis Campaign (Incorporating the Latex Allergy Support Group) (the ‘charitable company’) for the year ended 31 December 2020 which comprise statement of financial activities, balance sheet and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

We have nothing to report in respect of the following matters in relation to which the ISAs (UK) require us to report to you where:

Other information

The trustees are responsible for the other information. The other information comprises the information included in the trustees’ annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

12

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the trustees’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 11 the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

Paul Chamberlain (Senior Statutory Auditor) For and on behalf of Chamberlains Statutory Auditors and Chartered Accountants Elm House, Tanshire Park Shackleford Road, Elstead Godalming, Surrey GU8 6LB

Date:26 July 2021

13

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Statement of financial activities (incorporating an income and expenditure account)

Year ended 31 December 2020

Notes
Income from:
Donations
2
Other trading activities
2
Income from investments
3
Income from charitable activities
2
Total income
Expenditure on:
Raising funds
Charitable activities
Total expenditure
4
Net (losses)/gains on investments
11
Net income/(expenditure)
Transfer between funds
Net movement in Funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
15 / 16		 Total
Unrestricted
funds
Restricted
Funds
2020
£
£
£
382,487
63,387
445,874
77,668
-
77,668
1,582
-
1,582
97,157
-
97,157
558,894
63,387
622,281
28,188
-
28,188
384,097
82,776
466,874
412,285
82,776
495,062
(6,941)
-
(6,941)
139,668
(19,389)
120,279
28,756
(28,756)
-
168,424
(48,145)
120,279
384,914
55,641
440,555
553,338
7,496
560,834		 Total
Unrestricted
funds
Restricted
funds
2019
£
£
£
340,212
36,000
376,212
96,664
-
96,664
1,998
-
1,998
81,734
-
81,734
520,608
36,000
556,608
27,408
-
27,408
488,587
20,354
508,941
515,995
20,354
536,349
15,866
-
15,866
20,479
15,646
36,125
4,533
(4,533)
-
25,012
11,113
36,125
359,902
44,528
404,430
384,914
55,641
440,555

The Statement of financial activities includes all gains and losses in the year.

All income and expenditure derive from continuing activities.

14

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Balance Sheet

Year ended 31 December 2020

Note
Fixed Assets
Tangible assets
10
Investments
11
Current assets
Stock
Debtors
12
Cash at bank
13
Net current assets
Total assets less current liabilities
Funds
Restricted funds
16
Unrestricted funds
15
Total funds
Creditors - amounts falling due within one
year		 2020
£
15,407
156,150
171,557
2,193
64,051
357,362
423,606
(34,329)
389,277
560,834
7,496
553,337
**560,833 **		 2019
£
23,762
163,091
186,853
2,548
73,642
222,985
299,175
(45,473)
253,702
**440,555 **
55,641
384,914
**440,555 **

These financial statements have been prepared in accordance with the special provisions of Section 15 of the Companies Act 2006 relating to small companies.

Approved by the Trustees and authorised for issue on 16 May 2021 and signed on their behalf by:

Sarah Lassman - Trustee

Company Registration Number: 04133242

The notes on pages 17 to 28 form part of these financial statements.

15

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Statement of Cash Flows

Year ended 31 December 2020

Note
Cash flows from operating activities
20
Cash flows from investing activities
Purchase of fixed assets
Interest received
Net cash flow from investing activities
Net increase/(decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of year
Cash and cash equivalents at end of year		 2020
£
134,292
(1,497)
1,582
85
134,377
222,985
**357,362 **		 2019
£
16,463
(12,343)
1,998
(10,345)
6,118
216,867
222,985

16

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements

Year ended 31 December 2020

1. Accounting policies

General information

The Anaphylaxis Campaign (Incorporating The Latex AllergySupport Group) is a company limited by guarantee in the United Kingdom. In the event of the charity being wound up, the liabilityin respect of the guarantee is limited to £1 per member of the charity. The address of the registered office is given in the charity information on page 2 of thesefinancial statements. The nature of the charity's operations and principal activities are to: a) advance the education and general understanding of the public concerning life-threatening allergies and associated disorders; b) to protect the health of people whomay beat riskof severe allergic reactions byproviding help and informationto them, their family and friends; and c) to promote research intothe cause and care of severe allergic conditions and to publish the results of such research.

The charity constitutes a public benefit entity as defined by FRS102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordancewith the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102) issued on16July2014, the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS102), the Companies Act 2006 and UK Generally Accepted Practice.

Basis of preparation

The financial statements have beenprepared ona going concern basis under the historical cost convention, modified to include certain items at fair value.

The financial statements are prepared in sterling and monetary amounts are rounded to the nearest £.

The significant accounting policies applied in the preparation of these financial statements are set out below.

These policies have been consistently applied to all years presented unless otherwise stated.

Tangible Fixed Assets

All fixedassets to a value of £50 or more are capitalisedat cost. Depreciation is provided on all fixed assets at rates calculated to write off the cost of the asset over its expected useful life as follows:

Equipment: 25% straight line on cost.

Income recognition

All incoming resources are included in the Statement of Financial Activities (SoFA) when the charityis legally entitled to the income after performance conditions have beenmet, the amount canbemeasured reliably and it is probable that the income will be received.

Donations and subscriptions

Membership donations, memoriamdonations, major donors, legacies and charitable trust income is recognised on a receipts basis.

Corporate donations, corporate membership and professional membership income is recognised on a receivable basis.

17

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

1. Accounting policies (continued)

Income recognition (continued)

Donations and subscriptions (continued)

Individual membership received by direct debit is recognised on a receivable basis. For those members who pay by cheque or credit card, recognition is on a received basis.

Gift Aid income includes the Gift Aid on all applicable donations received in the year under review.

Gifts in kind

Donated professional services are recognised in income at their fair value when their economic benefit is probable, it can be measured reliably and the Campaign has control over the item. Fair value is determined on the basis of the value of the gift to the charity. For example the amount the charity would be willing to pay in the open market for such services. A corresponding amount is recognised in expenditure.

Community fundraising

Income is recognised on a received basis.

Event income and corporate sponsorship

Income earned from fundraising and sponsored events is recognised on the date the event is held.

Sale of educational products

Income is received for the sale of online "AllergyWise" courses written by the Campaign. Income is recognised on a received basis.

Product recall income

Product recall income is income received from retailers for the Campaign, contacting their members about mislabelled products. The invoiced amount is based on the type of product mislabelled, the difference types of alerts sent and the membership status of the retailer. Income is recognised on a receivable basis net of VAT.

Investment income

Investment income is earned through holding assets for investment purposes, and includes dividends and interest. Where it is not practicable to identify investment management costs incurred within a scheme with reasonable accuracy the investment income is reported net of these costs. It is included when the amount can be measured reliably. Investment income is recognised on a received basis.

18

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

1. Accounting policies (continued)

Expenditure

All expenditure is accounted for on an accruals basis and has been classified under headings that aggregate

Costs of raising funds: includes all direct fundraising costs, including costs of staff specifically engaged in community, trust and corporate fundraising. Costs of charitable activities: includes all costs (including support costs) for the Campaign's activities in meeting our charitable objectives. Governance costs: includes costs incurred in the governance of the charity and its assets, primarily associated with constitutional and statutory requirements.

Support costs allocation

Support costs are those that assist the work of the charity but do not directly represent charitable activities and include office expenses, governance costs, administrative payroll costs. They are incurred directly in support of expenditure on the objects of the charity and include project management carried out at Headquarters. Where support costs cannot be directly attributable to particular headings they have been allocated to cost of raising funds and expenditure on charitable activities on a basis consistent with use of the resources. Premises and other overheads have been allocated on an accruals basis.

Fund-raising costs are those incurred in seeking voluntary contributions and do not include the costs of disseminating information in support of the charitable activities.

The analysis of these costs is included in note 5.

Debtors

Trade and other debtors are recognised at the settlement amount due after any discounts offered to members. Prepayments are valued at the amount prepaid.

Cash at bank

Cash at bank includes cash and fixed term deposit accounts with a short term maturity of twelve months.

Creditors and provisions

Creditors and provisions are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured or estimated reliably. Creditors and provisions are normally recognised at their settlement amount after allowing for any discounts due.

Fund accounting

Unrestricted funds are available to spend on activities that further any of the purposes of the Campaign. Designated funds are unrestricted funds of the charity which the Trustees have decided at their discretion to set aside to use for a specific purpose. Restricted funds are donations which the donor has specified are to be solely used for particular areas of the Campaign's work or for specific projects being undertaken by the Campaign.

19

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

1. Accounting policies (continued)

Leasing

Rentals payable under operating leases are charged against income on a straight line basis over the lease term.

Taxation

The charitable company's activities are exempt from taxation under Sections 466-493 of the Corporation Tax Act 2010.

Investments

The carrying value of the investment at the accounting date represents the fair value of the underlying quoted investments and deposits.

The net realised and unrealised gains and losses of the underlying investments are reflected through the statement of financial activities.

Pensions

The charity operates a defined contribution plan for the benefit of its employees. Contributions are expensed as they become payable.

20

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

2. Incoming resources

Donations
Membership donations
Memoriam donations
Corporate donations
Charitable trust income & major donors
Legacies
Gift aid
Community fundraising
Individual membership
Professional membership
Corporate memberships
Other - including COVID support funding		 2020
£
30,595
7,340
4,414
56,550
103,965
18,814
42,734
55,701
6,252
64,115
55,393
**445,873 **		 2019
£
31,669
34,645
15,407
39,300
2,000
21,290
84,831
59,521
6,281
68,260
13,008
376,212

Included in legacies are amounts of £102,965 from the estate of Penelope Sibson and £1,000 from the estate of Wendy Thomson.

Other trading activities
Sale of goods
Advertising
Event income
Corporate sponsorship
Special project income
Other
Charitable activities
Sale of education products
Product recall income
3. Income from investments
Bank Interest		 2020
£
4,668
720
-
-
63,687
8,593
77,668
2020
£
36,932
60,225
97,157
2020
£
**1,582 **		 2019
£
5,681
970
25,791
16,250
37,369
10,603
96,664
2019
£
25,223
56,511
81,734
2019
£
1,998

21

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

4. Total expenditure
Activities
undertaken
directly
Support
costs
Total 2020
£
£
£
Raising f unds
28,188
-
28,188
Charitable activ ities
219,243
221,317
440,560
Gov ernance costs
-
26,314
26,314
Total
247,431
247,631
495,062
5. Allocation of support costs
Support
costs Total 2020
£
£
Staf f costs
92,246
92,246
70,853
70,853
Trav el expenses
1,554
1,554
Legal / Prof essional costs
26,706
26,706
Finance expenses
5,195
5,195
Website costs
5,617
5,617
Depreciation
9,852
9,852
Other costs
9,294
9,294
221,317
221,317
6. Allocation of governance costs
Activities
undertaken
directly
Total 2020
£
£
Staf f costs
19,086
19,086
Audit f ees
5,750
5,750
Trav el and subsistence expenses
1,478
1,478
26,314
26,314
Basis of apportionment
Staf f time
Inv oiced ev ents
Non-gov ernance expenses
Inv oiced ev ents
Bank charges pay able
Estimated usef ul lif e
Inv oiced ev ents
Of f ice rental and other
of f ice costs
Sof tware cost and usage		 Total 2019
£
27,408
485,821
23,121
536,350
Total 2019
£
82,930
74,467
9,644
3,790
4,727
7,072
13,327
13,245
209,202
Total 2019
£
15,143
6,500
1,478
23,121

22

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

7. Staff

The average monthly number of employees and full time equivalent (FTE) during the year was as follows:

2020
2020
Number
FTE
Raising funds
3
2
Charitable activities
10
8
Governance
-
-
13
10
Staff costs
Wages & salaries
Employers NI
Pension costs
The total staff costs and employees benefits was as follows:		 2019
Number
3
10
-
13
2020
£
277,830
17,208
4,865
**299,903 **		 2019
FTE
2
8
-
10
2019
£
295,303
19,380
5,122
319,805

None of the Trustees was employed by the Campaign, or had any interest in any contracts with the Campaign in either year. During the year £302 in respect of travel was reimbursed to two Trustees for expenditure incurred on the Campaign's business (2019: £1,189 - three Trustees).

No employee was paid more than £60,000 in either 2020 or 2019.

The key management personnel of The Campaign is the Chief Executive Officer, whose employee benefits total £53,796 (2019: £52,162).

8. Net income / (expenditure) for the year

The net income / (expenditure) is stated after charging / (crediting):
Depreciation of tangible fixed assets
Operating lease rentals		 2020
£
9,852
29,000		 2019
£
13,327
29,000

9. Auditor's remuneration

The auditor's remuneration amounts to an audit fee of £5,000 (2019: £5,000)

23

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

10. Fixed assets

10. Fixed assets
Cost
At 1 January 2020
Additions
Disposals
At 31 December 2020
Depreciation
At 1 January 2020
Charge for the year
Disposals
At 31 December 2020
Net book value
At 31 December 2020
At 31 December 2019		 Equipment
£
122,498
1,497
(37,877)
**86,118 **
98,736
9,852
(37,877)
**70,711 **
**15,407 **
23,762

24

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

11. Investments

Market v alue at 1 January
Additions
Disposals
Unrealised (loss)/gain on rev aluation
Market value at 31 December		 2020
£
163,091
-
-
(6,941)
156,150		 2019
£
147,225
-
-
15,866
163,091
Quoted inv estments
UK - equities
Cash f und		 Market value
Cost
£
£
155,115
132,963
1,035
1,035
156,150
133,998
2020		 Market v alue
Cost
£
£
161,479
132,963
1,612
1,612
2019
163,091
134,575

Included in the market v alue of inv estments at 31 December 2020 indiv idual inv estments that are material to the inv estment portf olio v aluation were:

No. of Cost at 31 Percentag
ordinary December e of total
shares / units Market v alue 2020 v aluation
HL Multi-Manager Income & Growth Trust 73,493 £ 63,513
 £ 56,392
 40.7%
HL Multi-Manager Strategic Bond Trust 40,872 £ 63,629
 £ 52,364
 40.7%
HL Multi-High Income Trust 15,731 £ 15,960
 £ 16,193
 10.2%

The income shown abov e is af ter management f ees.

12. Debtors

Trade debtors
Prepay ments
Accrued income
HMRC VAT liability (repay ment)		 2020
£
18,279
38,934
4,758
2,080
64,051		 2019
£
29,630
32,604
5,040
6,368
73,642

25

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

13. Creditors
Trade creditors
Other taxation and social security
Accruals
Deferred income (see note 14)
14. Deferred income
Income received in advance
At 1 January 2019
Amount released to incoming resources
Amount deferred in the year
As at 31 December 2019
Income in support of 2021 activities was the following:
Corporate Subscriptions		 2020
£
3,723
5,283
8,691
16,632
34,329
2020
£
16,632
2020
£
8,880
(8,880)
16,632
16,632
8,880
**8,880 **		 2019
£
22,358
6,908
7,327
8,880
45,473
2019
£
8,880
2019
£
5,670
(5,670)
8,880
8,880
8,880
8,880

Income has been deferred for the above sponsorship, donations and subscriptions as they relate to events which are due to take place in 2021.

15. Unrestricted funds

15. Unrestricted funds
General fund At 1 January
2020
Incoming
resources
Outgoing
resources
Gain on
investment
Transfer
to/from
unrestricted
At 31
December
2020
£
£
£
£
£
£
384,914
558,894
(412,285)
(6,941)
28,756
553,338
384,914
558,894
(412,285)
(6,941)
28,756
**553,338 **

Name of unrestricted fund

General fund

Description, nature and purpose of the fund The 'free reserves' after allowing for all designated funds.

26

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Notes to the financial statements (continued)

Year ended 31 December 2020

16. Restricted funds

At 1
January
2020
Incoming
resources
Outgoing
resources
Transfer
to/from
unrestricted
At 31
December
2020
£
£
£
£
£
Isle of Man Fund
6,293
6,293
Support for Adults
8,199
(8,199)
-
Support for Pharmacies
12,393
(12,393)
-
Mylan Spare Pens
28,756
(28,756)
-
10,000
(10,000)
-
Campaign for CCGs
4,500
(4,500)
-
Webinar for General Practice
1,500
(1,500)
-
DBV/Bresmed Project
232
(232)
-
Making Schools Safer Project
14,000
(14,000)
-
Back to School Campaign
22,500
(22,500)
-
Review of Educational Material
780
(780)
-
Switch Campaign
1,750
(1,750)
-
Mylan Speed Campaign
2,252
(2,252)
-
FSA Research Project
4,000
(3,700)
300
Survey, Review and Report
1,873
(970)
903
55,641
63,387
(82,776)
(28,756)
7,496
17. Analysis of net assets between funds
Unrestricted
Restricted
Total 2020
Total 2019
£
£
1
£
Fixed tangible assets
15,407
-
15,407
23,762
Fixed investment
156,150
-
156,150
163,091
Current assets
416,110
7,496
423,606
299,175
Current liabilities
(34,329)
-
(34,329)
(45,473)
553,338
7,496
560,834
440,555
Support for Primary Care		 At 1
January
2020
Incoming
resources
Outgoing
resources
Transfer
to/from
unrestricted
At 31
December
2020
£
£
£
£
£
6,293
6,293
8,199
(8,199)
-
12,393
(12,393)
-
28,756
(28,756)
-
10,000
(10,000)
-
4,500
(4,500)
-
1,500
(1,500)
-
232
(232)
-
14,000
(14,000)
-
22,500
(22,500)
-
780
(780)
-
1,750
(1,750)
-
2,252
(2,252)
-
4,000
(3,700)
300
1,873
(970)
903		 At 1
January
2020
Incoming
resources
Outgoing
resources
Transfer
to/from
unrestricted
At 31
December
2020
£
£
£
£
£
6,293
6,293
8,199
(8,199)
-
12,393
(12,393)
-
28,756
(28,756)
-
10,000
(10,000)
-
4,500
(4,500)
-
1,500
(1,500)
-
232
(232)
-
14,000
(14,000)
-
22,500
(22,500)
-
780
(780)
-
1,750
(1,750)
-
2,252
(2,252)
-
4,000
(3,700)
300
1,873
(970)
903
**55,641 ** 63,387
(82,776)
(28,756)
**7,496 **
Unrestricted
Restricted
Total 2020
Total 2019
£
£
1
£
15,407
-
15,407
23,762
156,150
-
156,150
163,091
416,110
7,496
423,606
299,175
(34,329)
-
(34,329)
(45,473)
553,338
7,496
560,834
440,555

18. Operating leases

Future minimum payments under non-cancellable operating leases are £36,250 (2019: £65,250).

19. Pensions

The charity operates a defined contribution pension plan for its employees. The amount recognised as an expense in the year was £4,865 (2019: £5,122) included within unrestricted charitable activities and support costs.

20. Reconciliation of Net Movement in Funds to Net Cash Flow from Operating Activities

Net movement in funds
Add back depreciation
(Deduct)/add back (gains)/losses on investments
(Deduct) interest income
(Increase)/decrease in stock
(Increase)/decrease in debtors
Increase/(decrease) in creditors
Net cash generated in operating activities		 2020
£
120,279
9,852
6,941
(1,582)
355
9,591
(11,144)
**134,292 **		 2019
£
36,125
13,327
(15,866)
(1,998)
(677)
(28,856)
14,408
16,463

27

Anaphylaxis Campaign (Incorporating The Latex Allergy Support Group)

Detailed income and expenditure account

Year ended 31 December 2020

2020 2019
£ £ £ £
Income
Subscriptions 126,068 134,062
Donations - members 30,595 31,669
Donations - other 246,477 125,650
Product Alerts income 60,225 56,511
Advertising & Sponsorship 720 17,220
Sale Proceeds 41,600 30,904
Community fundraising & events 42,734 110,622
Special project income 63,687 37,369
Other sundry income 8,593 10,603
Bank interest 1,582 1,998
622,281 556,608
Cost of sales (net of closing stock value) (2,798) (3,489)
619,483 553,119
Expenditure
Wages & salaries 299,903 319,805
Subcontract consultants 27,141 24,526
Communications, magazine, design 5,198 7,961
Website 5,617 7,072
Fundraising expenses 6,335 10,279
Conferences & events 1,650 20,955
Office expenses 1,881 3,134
Rent & rates 31,541 31,454
Light & heat 1,342 4,173
Staff training (84) 2,991
Staff recruitment - 10,335
Telephone & internet 4,355 4,550
Stationery & printing 1,117 1,779
Postage & carriage 3,973 5,329
Photocopying 320 1,055
Travel, subsistence & accommodation 3,032 11,122
Computer and software 23,917 20,752
Insurance 2,407 2,241
Bank charges 5,195 4,727
Audit 5,750 6,500
Professional fees 26,706 3,790
Depreciation 9,852 13,327
Subscriptions & journals 770 748
Sundry 487 1,162
Irrecoverable VAT 8,037 11,335
Bad debts - -
Special Projects & research grants 15,731 1,122
Support Groups 90 636
(492,263) (532,860)
Surplus for the year from operations 127,220 20,259
Gain/loss on investments (6,941) 15,866
Total surplus for the year 120,279 36,125

28